Biopsy Devices Market size to surpass $4.36 Billion by 2035 | Top players include Hologic, Inc., Becton, Dickinson and Company (BD), Medtronic plc, Cook Medical, Argon Medical Devices

Market Outlook and Forecast

The global biopsy devices market is undergoing a steady transformation, driven by the rising burden of cancer, increasing demand for minimally invasive diagnostic procedures, and advancements in imaging technologies. In 2025, the biopsy devices market is valued at USD 2.41 billion, and it is projected to reach USD 4.36 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.1% between 2026 and 2035. This sustained growth reflects the critical role biopsy procedures play in early disease detection, personalized medicine, and clinical decision-making.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-2565

Regional Performance Highlights

North America dominates the biopsy devices market, accounting for 44.2% of the global share during the forecast period. The region's leadership is attributed to advanced healthcare infrastructure, high cancer screening rates, strong reimbursement frameworks, and rapid adoption of innovative diagnostic technologies. The United States remains the primary contributor, supported by extensive research funding and a high prevalence of chronic diseases.

Europe follows as a mature market characterized by robust healthcare systems and increasing emphasis on early diagnosis. Countries such as Germany, the UK, and France are investing in precision medicine initiatives, which directly support the adoption of advanced biopsy devices. Regulatory harmonization across the European Union also facilitates smoother product approvals and market entry.

Asia Pacific is emerging as a high-growth region, fueled by expanding healthcare access, rising awareness of early cancer detection, and increasing investments in medical infrastructure. Countries like China, India, and Japan are witnessing growing demand for cost-effective biopsy solutions, particularly in urban healthcare centers. Government-led screening programs and private sector expansion are further accelerating market penetration.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. Biopsy Devices Market Report Overview here: https://www.researchnester.com/reports/biopsy-devices-market/2565

Market Segmentation

From a product segmentation perspective, the needle-based biopsy guns segment holds the highest share at 43.8%. These devices are widely preferred due to their precision, ease of use, and compatibility with image-guided procedures. Their application spans multiple specialties, including oncology, pulmonology, and gastroenterology, making them indispensable in modern diagnostics.

In terms of application, the breast biopsy segment is expected to dominate during the forecast period. The increasing incidence of breast cancer globally, combined with widespread screening programs such as mammography, is driving demand for accurate and minimally invasive biopsy techniques. Vacuum-assisted and core needle biopsy devices are particularly gaining traction for their ability to provide reliable tissue samples with minimal patient discomfort.

➤ Discover how the Biopsy Devices Market is evolving globally - access your free sample report → https://www.researchnester.com/sample-request-2565

Top Market Trends Transforming the Biopsy Devices Industry

1. Shift Toward Minimally Invasive and Image-Guided Procedures

One of the most significant trends in the biopsy devices market is the growing preference for minimally invasive procedures. Patients and healthcare providers alike are prioritizing techniques that reduce recovery time, minimize complications, and improve diagnostic accuracy.

Image-guided biopsy technologies-such as ultrasound, MRI, and CT-guided systems-are increasingly integrated with advanced biopsy devices. These systems allow clinicians to precisely target suspicious tissues, significantly improving diagnostic yield. For example, MRI-guided breast biopsies are becoming standard practice in complex cases where traditional imaging falls short.

This shift is also influencing product design, with manufacturers focusing on ergonomic, lightweight, and user-friendly devices that enhance procedural efficiency.

2. Integration of Artificial Intelligence and Digital Pathology

Digital transformation is reshaping the biopsy ecosystem. Artificial intelligence (AI) is being integrated into diagnostic workflows to assist in image analysis, lesion detection, and decision support.

AI-powered platforms can analyze biopsy samples more rapidly and accurately, reducing the risk of human error and enabling faster diagnosis. In addition, digital pathology solutions are allowing remote analysis of biopsy samples, which is particularly beneficial in regions with limited access to specialized pathologists.

Recent developments include AI-assisted biopsy guidance systems that help clinicians identify optimal sampling locations in real time, thereby improving diagnostic accuracy and reducing repeat procedures.

3. Rising Demand for Liquid Biopsy Technologies

Although traditional tissue biopsy remains the gold standard, liquid biopsy is gaining momentum as a complementary diagnostic tool. Liquid biopsy involves analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples, offering a non-invasive alternative for cancer detection and monitoring.

This trend is particularly relevant in oncology, where repeated tissue biopsies can be invasive and challenging. Liquid biopsy enables continuous monitoring of disease progression and treatment response, making it an attractive option for personalized medicine.

While still in the early stages compared to conventional biopsy devices, ongoing research and clinical validation are expected to expand the role of liquid biopsy in routine diagnostics.

➤ Unlock detailed analysis of key market trends transforming hybrid mobility. Get your sample report → https://www.researchnester.com/sample-request-2565

Recent Company Developments

The biopsy devices market is highly competitive, with leading players focusing on innovation, strategic partnerships, and geographic expansion. Over the past 12 months, several notable developments have shaped the competitive landscape:

Hologic, Inc.: Hologic has strengthened its position in the breast biopsy segment through the launch of advanced vacuum-assisted biopsy systems. The company has also invested in AI-driven imaging technologies to enhance diagnostic accuracy and workflow efficiency.

Becton, Dickinson and Company (BD): BD has expanded its biopsy portfolio with new needle-based devices designed for improved precision and safety. The company has also focused on integrating its biopsy solutions with imaging platforms to support minimally invasive procedures.

Medtronic plc: Medtronic has made strategic investments in robotic-assisted biopsy technologies, aiming to improve targeting accuracy in complex procedures such as lung biopsies. The company is also exploring partnerships to enhance its digital health capabilities.

Cook Medical: Cook Medical has introduced new biopsy needles optimized for endoscopic ultrasound (EUS)-guided procedures. These innovations are particularly relevant in gastrointestinal and pancreatic cancer diagnostics.

Argon Medical Devices: Argon Medical has expanded its product line with advanced soft tissue biopsy instruments. The company has also focused on strengthening its distribution network in emerging markets to capture growing demand.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-2565

Related News:
https://www.linkedin.com/pulse/endotracheal-tubes-market-trends-innovations-modern-airway-ghumreg-dtbwf

Contact Data
AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.